Cartesian Therapeutics (RNAC) has shared an update.
Cartesian Therapeutics, Inc., a player in the biotech field, has signed a lease for a new manufacturing and office facility in Maryland, signaling a significant expansion move set to commence by April 2024. With a space of 20,000 square feet, the lease term spans seven years, featuring an annual rent increase and an extension option. Meanwhile, the company also announced the immediate resignation of long-serving board member Aymeric Sallin, who leaves amicably to pursue other opportunities. This strategic real estate move and board change were disclosed as part of the company’s commitment to growth and corporate transparency.
For a thorough assessment of RNAC stock, go to TipRanks’ Stock Analysis page.
